Study Objectives: Based on the fact that erythropoietin (Epo) administration in rodents protects against spatial learning and cognitive deficits induced by chronic intermittent hypoxia (CIH)-mediated oxidative damage, here we tested the hypothesis that Epo in the brain protects against cardiorespiratory disorders and oxidative stress induced by CIH in adult mice.
Introduction
Sleep apnea or sleep-disordered breathing (SDB) is of deep public health concern and the second most frequent respiratory disorder in North America [1, 2] . SDB is characterized by repeated episodes of cessation of breathing followed by brief and repeated arterial oxygen desaturations, or chronic intermittent hypoxia (CIH) [3, 4] . CIH increases the production of reactive oxygen species (ROS) by increasing the activity of pro-oxidant enzymes and decreasing the activity of antioxidant enzymes [5, 6] . The resulting oxidative stress induces inflammation, tissue injury, and long-lasting alterations to the chemical structure of proteins, fatty acids, and DNA. As such, CIH induces significant cardiovascular and metabolic pathologies [1, 3, [6] [7] [8] , but also cognitive and behavioral deficits [9] . In fact, by comparison with other tissues, the brain is especially vulnerable to oxidative stress because it consumes a large fraction of total oxygen, has lower antioxidant enzyme activity, possesses a high concentration of metal ions capable of forming hydroxyl radicals via the Fenton reaction, and is rich in polyunsaturated fatty acids [10, 11] , which are targets of lipid peroxidation [12, 13] . Furthermore, studies in humans showed that neurobehavioral impairments induced by CIH are the result of increased levels of oxidative stress, inflammation, and gray matter loss [9, 14, 15] . Neurodegenerative changes, increased oxidant stress, inflammation, and impaired learning were also evident when episodes of CIH were replicated in rodents [16] [17] [18] [19] [20] [21] [22] [23] [24] . On the basis of these findings, it has been proposed that antioxidant drugs could be an effective strategy for preventing morbidities associated with the oxidative stress [6, 25] . In line with this reasoning, previous studies have demonstrated that erythropoietin (Epo-a cytokine mainly known for its role in the regulation of erythropoiesis) produced in the brain (neurons and astrocytes) has neuroprotective and antioxidative effects [26] [27] [28] [29] [30] [31] [32] , and Epo administration protects against the deleterious impacts of CIH on the brains of rodents. Specifically, in rats exposed to CIH, Epo attenuated the spatial learning deficits and hippocampal oxidative stress by reducing lipid peroxidation and increasing the expression of antioxidant enzymes such as glutathione peroxidase [33] . Similarly, Epo administration attenuated the CIHinduced cognitive deficits by reducing the expression of NADPH and lipid peroxidation in a murine model of sleep apnea [34] .
Based on this background, and on studies performed in our laboratory showing that murine cerebral Epo interacts with the respiratory centers located in the brainstem to modulate ventilation and increase the ability to tolerate hypoxic conditions [35] [36] [37] [38] , we hypothesized that cerebral Epo protects against the cardiorespiratory dysfunction and oxidative stress induced by CIH. To test this hypothesis, we used control and transgenic mice overexpressing Epo only in the brain (Tg21), to evaluate the incidence of apneas, arterial pressure, and basal, hypoxic, and hypercapnic breathing induced by CIH. Moreover, the activity of pro-and antioxidant enzymes in cytosolic and mitochondrial extracts of the brainstem was assessed. Our results show that cerebral Epo prevents CIH-mediated cardiorespiratory dysfunctions by regulating the production of oxidative stress.
Materials and Methods

Animals
Three-month-old transgenic Tg21 mice were used in this study. In our laboratory, Tg21 heterozygous mice were backcrossed with C57Bl/6 mice for more than six generations to obtain the corresponding control mice. Overexpression of Epo in Tg21 mice occurs only in the brain (fourfold higher vs. control). Therefore, they maintain normal plasma levels of hematocrit. A detailed description of the Tg21 strain was reported previously (in the works of Ruschitzka et al. and Wiessner et al.) . Mice were housed and bred in a light-controlled room, which was maintained at a constant temperature (22ºC) and humidity on a 12 hr light cycle (07: 30-19:30) . They had free access to food (Commercial diet; 2018 Teklad Global 18% Protein Rodent Diet; Harlan Laboratories, Montreal, QC, Canada) and water. Animal experiments were approved by the Laval University Animal Ethics Committee and carried out in accordance with the standards and guidance of the Canadian Council on Animal Care.
Chronic intermittent hypoxia
Mice were exposed to CIH during 7 days, for 8 hr per day. As such, animals were placed in a Plexiglas chamber from 8:00 am to 4:00 pm. Oxygen level fluctuations were accomplished by the use of an Oxycycler (Biosperix, Redfield, NY). Setup of the CIH chamber was done as described previously [5, 39] . In a day, 80 cycles of normoxia-hypoxia fluctuations took place, with each cycle lasting 5 min. At the beginning of each cycle, the animals were exposed to 1 min of normoxia (21% O 2 ) followed by a drop from 21 to 10 per cent O 2 over 1.5 min. Then, hypoxia was sustained for 1 min after which the oxygen level was returned from 10 per cent back to 21 per cent O 2 over 1.5 min. Control animals were exposed to normoxic room air (RA) under otherwise identical housing conditions.
Heart rate and arterial blood pressure
Heart rate and mean arterial blood pressure (MAP), systolic arterial blood pressure (SAP), and diastolic arterial blood pressure (DAP) were assessed after exposure to CIH. Heart rate and arterial blood pressure were measured by the tail cuff method by volume pressure recording (CODA system-Kent Scientific, Torrington, CT, USA) in conscious animals at RA, between noon and 1:00 pm. The tail cuff method is reliable and comparable to telemetry measurements using an aortic catheter [40] . Mice were placed in a cylindrical holder over a warmed blanket. After 30 min of habituation, at least 8 recordings were performed, each separated by 5 min. Our data report the mean of the lowest five values for SAP, DAP, and MAP.
Respiratory recordings
Respiratory recordings were performed after 7 days in CIH by using the whole-body plethysmography technique in freely behaving, unrestrained mice (Emka Technologies, Paris, France). Airflow through the chamber was set at ≈250 mL/min, at room temperature. A differential pressure transducer (Emka technologies) was connected between the recording chamber and the built-in reference chamber. A single injection of 500 µL of air inside the chamber was used for calibration of the flow trace. The signal was acquired and recorded on a computer using Spike 2 software (Cambridge Electronic Design, Cambridge, UK), and the same program was used offline to calculate respiratory frequency (Rf), tidal volume (Vt), and minute ventilation (V E = Rf x Vt).
Apneas, metabolism, and ventilatory parameters at rest, hypoxia, and hypercapnia Once animals were placed in the plethysmography chamber, restful breathing was recorded for 4 hr under normoxic conditions. This approach allows the evaluation of apneic events during stable sleep periods from the respiratory recordings [41, 42] . The number of apneic episodes was evaluated during periods of regular breathing pattern [41, 42] . Any cessation of breathing lasting more than two regular breaths was considered as an apneic event. By using standard equations described previously [35] , metabolism (oxygen consumption, VO 2 ; carbon dioxide production, VCO 2 ) was also calculated under basal normoxic conditions. Body weight was measured routinely after experiments to express the Vt in mL/100 g. Body temperature was measured at the beginning and end of the experiments with a rectal thermocouple probe for mice (Physitemp).
After 4 hr of basal (normoxic) ventilation, Rf, Vt, and V E were evaluated under conditions of hypoxia (12% O 2 ; 15 min), followed by a brief return to baseline (normoxia; 10 min), and finally hypercapnia (21% O 2 , 5% CO 2 , in N 2 ; 10 min).
Statistical analysis of ventilatory parameters
Metabolism and ventilatory parameters during normoxic conditions, MAP, as well as the number of apneic episodes were evaluated using a one-way ANOVA, followed by a Fisher's LSD test.
The effects of hypoxia and hypercapnia on the ventilatory parameters of each treatment group were analyzed using a mixed factor ANOVA (with oxygen condition and treatment group as factors). For the mixed factor ANOVA, post hoc tests were done using a correction for multiple comparisons. All analysis and graphs were done with the GraphPad prism 6.0 software (La Jolla, CA, USA). The data are shown as boxplots displaying minimum, first quartile, median, third quartile, and maximum. Differences were considered significant at p < 0.05.
Oxidative stress enzyme activities
Protein extraction and assays
At the end of the plethysmographic recordings, the animals were deeply anesthetized, and the brain cortex and brainstem were rapidly dissected, immediately frozen on dry ice, and kept at −80°C until further analysis. After homogenization in phosphate buffer, different centrifugations (all at 4°C) were used to isolate the cytosolic fraction. Briefly, the samples were centrifuged for 4 min at 1500 g, followed by a second centrifugation for 10 min at 12 000 g, after which the supernatant (cytosolic fraction) was collected. This fraction was stored at −80°C until analyses. The protein concentration in each fraction was determined by a standard colorimetric BCA assay kit (Thermo Scientific, catalogue #23225) and all subsequent measurements were normalized to protein concentration.
Xanthine oxidase
Xanthine oxidase (XO) activity was assessed using a cocktail containing nitroblue tetrazolium (NTB-2.2 mM in water), Tris-HCL pH 8 (2.8 mM), diethylene-triamine-penta-acetic acid (1.3 mM in Tris-HCL), and a fresh solution of hypoxanthine (500 μM in Tris-9HCL/well). Fifty microliters of sample, 200 μL of cocktail, and 30 μL of hypoxanthine solutions were added to each well and the plate was gently shaken for 40 min at room temperature. The absorbance of the complex (formazan blue) formed by NTB and the superoxide anion (produced by XO in the sample) was read at 560 nm, every 5 min for 1 hr; XO activity corresponded to the slope of the formation of formazan blue by time.
NADPH oxidase NADPH oxidase (NOX) activity was assessed using the same cocktail solution for XO, and a fresh solution of NADPH (1 mM). Twenty microliters of sample, 250 μL of cocktail, and 30 μL (100 μM/well) of NADPH were added to each well and the plate was shaken for 2 min at room temperature. The absorbance was read at 560 nm, every 50 s for 10 min. NOX activity corresponded to the slope of the formation of formazan blue by time.
Superoxide dismutase
Superoxide dismutase (SOD) activity was determined by the degree of inhibition of the reaction between O 2 − (produced by a hypoxanthine-xanthine oxidase system) and NTB. We used the same cocktail described for XO and NOX activities plus hypoxanthine (0.19 mM). A fresh solution of xanthine oxidase (1.02 units/mL) was prepared, and then we added 20 µL of sample, 250 µL of cocktail, and 20 µL of XO to each well, and mixed the plate for 4-5 s at room temperature. The absorbance was quickly read at 450 nm, every 50 s for 5 min. For this assay, 4 wells were used as blanks, with 20 µL of PBS 1X rather than samples, and 1 mM of NaCN was added in all the wells to inhibit SOD from the cytosolic fraction. SOD activity corresponded to the difference between the slopes of the formation of formazan blue by time of the blank versus each sample.
Statistical analysis of the enzymatic activity
We used GraphPad prism software for all analyses. All data were analyzed using a one-way ANOVA followed by a post hoc test (Fisher's LSD). All data are shown as boxplots displaying minimum, first quartile, median, third quartile, and maximum. Differences were considered significant at p < 0.05.
Results
CIH does not affect body weight and rectal temperature
Body weight and rectal temperature were similar in control and transgenic mice exposed to CIH (Table 1) .
Cerebral Epo prevents the increase of heart rate and arterial pressure induced by CIH
The values of heart rate and MAP were significantly higher in Control-CIH mice compared with Control-RA mice. This increase was prevented in Tg21-CIH animals ( Figure 1A and B). As shown in Figure 1B and C, the increased MAP is a result of increased diastolic and systolic pressures. The Tg21-CIH mouse group showed levels of diastolic ( Figure 1B ) and systolic pressure ( Figure 1C ) comparable to control RA mice.
Cerebral Epo prevents the increase of apneic episodes induced by CIH
Ventilation, metabolism (O 2 consumption and CO 2 production), and the total number of apneic episodes in mice were evaluated during 2 hr of continuous sleep under normoxic conditions. CIH did not affect either ventilatory or metabolic parameters ( Figure 2 ). In contrast, CIH significantly increased the total number of apneic episodes in Control-CIH mice ( Figure 3A ). This effect was due to increases in both spontaneous and post-sigh apneas ( Figure 3B and C) . Interestingly, the increase in total number of apneic events was prevented by cerebral Epo, as shown in the Tg21-CIH animal group ( Figure 3A) , with Tg21-CIH mice showing levels of spontaneous ( Figure 3B ) and post-sigh ( Figure 3C ) apneas similar to those of the control-RA group.
The hypoxic ventilatory response and hypercapnic ventilatory response were increased by CIH, and Epo prevents such effects
Normoxic basal ventilation (V E ), respiratory frequency (Rf), and tidal volume (Vt) evaluated in mice were similar between animals from the Control-RA, Control-CIH, and Tg21-CIH groups ( Figure 4A and C, Nx). However, CIH significantly increased the hypoxic ventilatory response (HVR) and hypercapnic ventilatory response (HcVR) of control-CIH animals compared with control-RA mice ( Figure 4A) . Interestingly, the HVR of Tg21-CIH mice was significantly lower than that of the control-CIH group, and the HcVR of these transgenic mice also tended to be more similar to the control-RA mice. The increased HVR and HcVR in control-CIH mice were due to elevated Vt ( Figure 3C ), rather than Rf ( Figure 3B ). Compared with control-CIH, attenuation of the HVR in Tg21-CIH mice was due to a significantly lower Rf, rather than Vt ( Figure 4B and C). During hypercapnia, the Rf tended to be lower in Tg21-CIH mice compared with Control-CIH; however, there were no significant differences between Rf and Vt in these two groups.
Cerebral Epo protects against a pro-oxidant status during exposure to CIH
Exposure to CIH increased XO activity in the cortex of control-CIH mice, whereas overexpression of cerebral Epo in the Tg21-CIH group prevented this increase ( Figure 5A ). Similar measurements performed in the brainstem failed to detect XO activity ( Figure 5B ). Exposure to CIH increases NOX activity in the cortex of control-CIH mice, and this was prevented in Tg21 mice exposed to CIH ( Figure 6A) . Conversely, no effect of CIH or cerebral Epo was observed in the NOX activity of brainstem tissue, as similar No changes in these parameters between groups were observed. data were found among control-RA, control-CIH, and Tg21-CIH groups ( Figure 6B ). The activity of the mitochondrial antioxidant enzyme SOD was also evaluated in cortex and brainstem tissue samples. In the cortex, there were no differences in SOD activity between control-RA and control-CIH groups. However, SOD activity was significantly lower in Tg21-CIH animals ( Figure 7A ). In contrast, there were no differences in mitochondrial SOD activity in brainstem tissue among control-RA, control-CIH, and Tg21-CIH groups ( Figure 7B) .
The balance between pro-and antioxidants was calculated by the ratio of NOX/SOD. As expected, CIH promoted an increased NOX/SOD ratio, as shown by the comparison between control-RA and control-CIH groups ( Figure 8A) . Interestingly, the increased NOX/SOD ratio was prevented by overexpression of cerebral Epo in Tg21-CIH animals ( Figure 8B ).
Discussion
In the present study, we exposed transgenic mice overexpressing Epo in the brain only (Tg21) to CIH (a model to study sleep apnea) to determine whether cerebral Epo prevents CIH-induced cardiorespiratory dysfunctions. Furthermore, because CIH induces mitochondrial dysfunction and production of ROS in neural tissue [16, 17, [19] [20] [21] [22] , we tested the hypothesis that the Epo-related protective mechanism includes the regulation of oxidative stress. Our results clearly show that central Epo overexpression prevents the CIH-induced increase of apnea incidence, cardiorespiratory dysfunction, and oxidative stress.
Sleep apnea and the associated CIH
Sleep apnea is a highly prevalent clinical condition across the life span that imposes important adverse cardiorespiratory and neurobehavioral consequences. Such morbidities are associated (at least in part) with imbalances in the oxidative stress and inflammatory regulating systems resulting from the CIH that characterizes this illness [19, 25, 34] . In humans suffering from sleep apneas, there are clear-cut signs of oxidative stress such as excessive ROS production in leukocytes, increased lipid peroxidation (caused by free radicals), and reduced antioxidant capacity [9, 14, 15] . Furthermore, oxidative stress correlates with markers of cardiovascular diseases such as endothelial dysfunction and high blood pressure [43] . CIH and elevated ROS production also activate transcription factors that enhance the expression of proinflammatory pathways, leading to dysfunction of the vascular endothelium (characterized by a failure to properly respond to mediators of vasodilatation), promotion of atherosclerosis, and reinforcement of arterial hypertension [6] . In line with these known outcomes, studies performed in rodents showed that exposure to CIH (a protocol regularly used to mimic sleep apnea in the laboratory [44] [45] [46] ) increased cellular levels of ROS that contributed to organ injury, including the brain [16] [17] [18] [19] [20] [21] [22] [23] [24] . Several studies in humans showed that neurobehavioral impairments induced by CIH are the result of increased levels of oxidative stress, inflammation, and gray matter loss [9, 14, 15] . Importantly, CIH is also associated with overstimulation of peripheral chemoreceptors and the brainstem areas receiving terminal nerves from the carotid bodies [43] [44] [45] . In fact, excessive input from peripheral chemoreceptors contributes to respiratory instability and higher incidence of apneas [47] . Moreover, increased sensitization of the carotid bodies due to ROS production was observed in rats exposed to CIH, and treatment with superoxide dismutase abolished such sensitization [48, 49] . Similarly to what happens at the central level, peripheral CIH-mediated ROS induction also triggers the production of proinflammatory cytokines (such as IL-1B and TNF-α), thus inducing local inflammation [44, 50, 51] . Accordingly, it was shown in the rat carotid body that daily treatment with antiinflammatory drugs (dexamethasone or ibuprofen) decreased the levels of oxidative stress [52] . It is important to note that dysfunction of peripheral chemoreceptors leads to activation of the sympathetic system and concomitant hypertension [53] [54] [55] . Consistent with these studies, our results show that CIH increases the heart rate, the arterial pressure, and the ventilatory response to hypoxia and hypercapnia.
Cerebral Epo protects the cerebral cortex against CIH-induced oxidative stress
In brain tissue, Epo is involved in neuroprotection [56] , neurogenesis [57, 58] , and angiogenesis [58, 59] and plays an important role as a neurotrophic factor [60, 61] . More recently, studies have reported that Epo also regulates mitochondrial energy metabolism in several nonhematopoietic tissues [62] . Epo increases mitochondrial biogenesis, cellular oxygen consumption, and fatty acid metabolism in adipocytes [63, 64] ; Epo regulates lipid metabolism, thermogenesis, and fat oxidation in skeletal muscles [65] ; Epo treatment enhances the oxidative phosphorylation and electron transport capacities of human skeletal muscle mitochondria [66] ; and Epo promotes eNOS activation to provide cardioprotection [67] [68] [69] [70] . In the brain, Epo prevents mitochondrial dysfunction after traumatic brain injury by inhibiting the opening of mitochondrial permeability transition pores (mPTPs), thereby maintaining the mitochondrial membrane potential and calcium homeostasis [71] . Specifically concerning sleep apnea, it was shown in mice that administration of exogenous Epo attenuates the CIH-induced cognitive and behavioral deficits such as anxiety symptoms and spatial learning deficits. These effects of Epo were due to the prevention of elevated levels of NADPH oxidative expression, lipid peroxidation, and 8-hydroxydeoxyguanosine (8-OHDG) in cortical and hippocampal lysates [34] . In line with these results, rats exposed to CIH and treated with Epo showed attenuated spatial learning deficits and hippocampal oxidative stress, resulting from reduced lipid peroxidation and increased production of antioxidant enzymes (such as glutathione peroxidase) [33] . Accordingly, our results show that the increased activity of XO and NOX induced by CIH in the cortex is prevented by the overexpression of cerebral Epo. Moreover, although SOD activity in the cortex was unchanged, the balance between the activities of pro-/anti-oxidants, expressed by the ratio NOX/SOD, was increased by CIH and prevented by cerebral Epo.
Cerebral Epo protects against the cardiorespiratory alterations induced by CIH
Our results show that cerebral Epo prevents the CIH-induced increase of NOX/SOD ratio, and accordingly, heart rate, arterial pressure, apneic episodes, and ventilatory responses to hypoxia were unchanged by CIH in Tg21 mice. In fact, these results suggest that Epo in the brainstem may be involved in the cardiorespiratory protection against CIH-induced oxidative stress. Central sites for oxygen sensitivity are present in cardiorespiratory areas of the brainstem, such as the nucleous tractus solitarius (NTS) [72] , the C1 sympathoexcitatory region [73, 74] , and the pre-Bötzinger complex [75] [76] [77] . Likewise, research performed in our laboratory showed that neurons from the NTS, the PBC, and several catecholaminergic nuclei (A1/C1; A2/C2, A5, and A6) Significantly different from the corresponding normoxic level: *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001; significantly different between treatment groups: # p < 0.05, ## p < 0.01.
express EpoR [36] . Furthermore, in vivo studies performed in Tg21 mice suggested that cerebral Epo enhances hypoxic ventilation by modulating catecholamine synthesis both in pontine and medullary areas of the brainstem [36] . Despite the fact that Epo's impacts on catecholamines have not been directly tested, in vitro studies performed in en bloc brainstem-spinal cord preparations showed that Epo counteracts the decrease in respiratory motor output during a hypoxic challenge [78] . Based on these findings, previous research established that modulation of catecholamines in brainstem nuclei [79, 80] was associated with increased blood pressure induced by IH [81, 82] . Considering this evidence as a whole, it is tempting to speculate that the prevention of CIHinduced cardiorespiratory dysfunctions by Epo that we observed in our results is mediated, at least in part, by regulation of catecholaminergic activity in brainstem cardiorespiratory centers.
On the other hand, hemeoxygenase (HO) is an oxygen-sensing molecule and antioxidative stress protein necessary for the oxygen-sensing function of the cardiorespiratory regions in the rostral ventrolateral medulla (RVLM) [83] . Although HO-2 and HO-3 isoforms are expressed constitutively, HO-1 is inducible and expressed in response to hypoxia, oxidative stress, and other stimuli [84, 85] . Furthermore, expression of HO-1 was found in the C1 and pre-Bötzinger regions in response to chronic hypoxia [86] and CIH [87] . Interestingly, it was revealed that Epo's cytoprotective and antioxidant properties in kidney [88] and SH-SY5Y cells [89] involved in the upregulation of HO-1.
In agreement with these previous studies, we found that the protective effect of Epo was more important for the HVR (which may depend on HO-1 mechanisms) rather than the HcVR. Based on this evidence, it could be speculated that Epo-mediated activation of HO-1 in RVLM regions may also help us to attenuate the CIH-induced cardiorespiratory dysfunctions observed in the present study.
Apart from central regulation, and as mentioned above, the overstimulation of peripheral chemoreceptors resulting from CIH provides an important contribution to respiratory instability, leading to a higher incidence of apneas [47] and excessive HVRs [90] . Data obtained in this study also suggest that the carotid bodies are implicated in the cardiorespiratory alterations induced by CIH. Despite the small size of peripheral chemoreceptors in mice, which limits the ability to perform experiments at this level, it is known that carotid body cells (Type I and Type II) are of neural origin. As such, it is possible that overexpression of Epo also occurs within this organ in Tg21 mice. If that the case, Epo might contribute to decreasing oxidative stress and inflammation mediated by CIH at the carotid body level. Supporting this hypothesis, previous studies showed that the carotid bodies of mice express EpoR [38, 91] , and that CIH increases the expression of EpoR in the carotid body of rats [92] .
Finally, a recent study from our laboratory reported that estradiol replacement in ovariectomized (ovx) female rats protects against cardiorespiratory dysfunction and oxidative stress induced by CIH [41] . In fact, results obtained with estradiol were highly similar to the data reported in this work. Although CIH increased arterial pressure, number of apneic events, minute ventilation, and the ratio of pro-/antioxidants in the cortex and brainstem, estradiol replacement prevented both physiological and oxidative changes. Such results are not surprising when considering that Epo and estradiol have similar effects in the neural tissue. In fact, both molecules were reported to have antioxidant, anti-inflammatory, anticytotoxic, antiapoptotic, and protective properties in brain tissue [93, 94] . Furthermore, as a close relationship exists between Epo and estradiol at the circulating level [95, 96] , it is tempting to suggest that investigating the relationship between Epo and estradiol in brain tissue will help us to better understand the molecular mechanisms leading to sleep apnea.
In conclusion, brain Epo in mice protects against CIHmediated increases in apneic frequency, respiratory dysfunction, and elevation of arterial blood pressure. At the central level, our results strongly suggest that Epo expression is associated with tissue protection against oxidative stress. Concerning the CIH-associated sympathetic activation, our results suggest that Epo in the carotid body might also decrease oxidative stress in these organs, which might also contribute to alleviating systemic and neurological impairments. As Epo crosses the blood brain barrier [97] [98] [99] , our data suggest that Epo could be used as a target drug to protect against the deleterious consequences of sleep-disorder breathing. 
